一文列出京東健康(06618.HK)與行業龍頭營運數據比較
西南證券發表京東健康(06618.HK)研究報告,指京東健康作為互聯網醫療行業後起之秀,其B2C(公司對個人交易)自營電商「京東大藥房」、B2B(企業對企業)「藥京採」目前均已處於行業領先水,指公司已經實現了在內地基本的互聯網醫療基建,隨著用戶醫療消費習慣的培養、政策的逐漸明朗預計將進入爆發階段,建議積極關注,但該行無給予投資評級及目標價。
西南證券列出京東健康與行業龍頭公司包括阿里健康(00241.HK)、平安好醫生(01833.HK)業務數據比較:
股份│京東健康│阿里健康│平安好醫生
競爭力│背靠京東(年活躍用戶4.4億)│背靠阿里(年活躍用戶7.6億)│背靠平安
模式│電商起家,醫藥閉環│電商起家,醫藥閉環│掛號切入
醫生│6.85萬名合作醫生│3.9萬名合作醫生│1,836個自有團隊+5,978名合作醫生
日均問診量│9萬│疫情間一天曾破10萬人次│83萬
用戶數│1.5億(6月底止)│2.5億(9月底止)│3.4億(6月底止)
合作醫院│與30家醫院合作(連接3萬醫生)│二級和三級醫院逾4,000家│與近50家大醫院合作
去年收入│108億人幣│96億人幣│51億人幣
員工總數│1,411人│990人│2,900人
--------------------------------
京東健康與阿里健康、平安好醫生旗下藥品零售業務對比:
藥品零售業務對比
股份│京東健康│阿里健康│平安好醫生
可售賣出庫貨品種類(SKU)│逾1,000萬│-│131萬
自營品牌│京東大藥房│阿里健康大藥房│平安健康互聯網大藥房
第三方商家數量│9,000家│1.8萬家│11.1萬家
倉儲物流│11個藥品倉+230個其他倉│9個倉覆蓋七個地區│中心倉覆蓋40個城市
快遞時效│京東物流:當/次日達,覆蓋逾200城市│第三方物流,60座核心城市1次日達│第三方物流,40個中心倉覆蓋市平均一小時送達,自營商品48小時內諾送貨
年活躍用戶數│7,250萬(截至6月底)│6,500萬(截至9月底)│-
--------------------------------
京東健康與阿里健康、平安好醫生各業務營收入佔比
(1)京東健康
-醫藥和健康產品銷售(87.4%)
-線上平台、廣告及其他服務(12.4%)
以上據今年上半年資料
(2)阿里健康
-醫藥自營(84.3%)
-醫藥電商(12.9%)
-消費醫療(2.5%)
-追溯業務(0.3%)
以上據今年4月至9月底資料
(3)平安好醫生
-醫療業務(45%)
-醫藥業務(20%)
-消費型醫療(15.8%)
-健康管理及互動(3.9%)
以上據今年上半年資料
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.